Interest of the Intervention of a Nurse Coordinator in Complex Care Pathway
NCT04209491 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2020-01-09
Summary
This project is based on the assumption that the nurse coordinators of the centres have common missions at each of the key stages of patient care. These missions make the care plan more fluid and improve the quality and safety of care as well as the patient's prognosis.
The Hypothesis is that co-follow-up by a doctor and a nurse coordinator reduces time between referral to treatment, average lengths of stay, unscheduled readmissions or early emergency visits, compared to follow-up that does not involve a nurse coordinator.
Conditions
Sponsors & Collaborators
-
Assistance Publique - Hôpitaux de Paris
lead OTHER
Principal Investigators
-
Julie DEVICTOR · Assistance Publique - Hôpitaux de Paris
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-09-09
- Primary Completion
- 2020-02-01
- Completion
- 2020-02-01
Countries
- France
Study Locations
More Related Trials
-
Perception of the Doctor/Patient Relationship, Disease and Treatment Among Physicians and Their Patients Treated With Systemic Therapy for Hepatocellular Carcinoma "PERCEPTION1"
NCT04823754 ·Status: COMPLETED
-
COVID-19 Infection in Patients With Hepatocellular Carcinoma
NCT04367805 ·Status: ACTIVE_NOT_RECRUITING
-
Novel Subtypes and Treatment Strategies of Patients with Unresectable Combined Hepatocellular Cholangiocarcinoma Based on Multimodal Data
NCT06849180 ·Status: RECRUITING
-
Study of Liver Resection With Versus Without Hepatic Inflow Occlusion for the HBV-related HCC
NCT02563158 ·Status: UNKNOWN ·Phase: NA
-
Sequential Treatment of Hepatocellular Carcinoma by Transarterial Chemoembolization and Local Ablation or External Radiation
NCT04813861 ·Status: COMPLETED
-
Therapeutic Assistance and Decision-making Algorithms in Hepatobiliary Tumor Boards
NCT05681949 ·Status: UNKNOWN ·Phase: NA
-
Ivosidenib Plus Durvalumab and Gemcitabine/Cisplatin as First-Line Therapy in Participants With Locally Advanced or Metastatic Cholangiocarcinoma With an IDH1 Mutation
NCT06501625 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Liver Resection Versus Radio-chemotherapy-Transplantation for Hilar Cholangiocarcinoma
NCT02232932 ·Status: UNKNOWN ·Phase: NA
-
PD-1 Inhibitor Combined With 125I Seed Implantation for Hepatocellular Carcinoma's Extrahepatic Metastasis: Efficacy and Safety
NCT06991907 ·Status: COMPLETED ·Phase: NA
-
Adjuvant Hepatic Arterial Infusional Chemotherapy After Curative Resection of Hepatocellular Carcinoma
NCT01088581 ·Status: COMPLETED ·Phase: PHASE3
-
Transarterial Chemoembolization Plus Hypofractionnated Radiotherapy vs. Surgery in Locally Advanced Hepatocellular Carcinoma: an IPTW Comparison
NCT04823715 ·Status: COMPLETED
-
Anti-angiogenesis Combined With PD-1/PD-L1 Therapy in Patients With Advanced Liver Cancer
NCT05383066 ·Status: UNKNOWN
-
Resection And Partial LIver Transplantation With Delayed Hepatectomy for Hepatocellular Carcinoma
NCT05971628 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study of Factors Predicting Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma (HCC)
NCT01198704 ·Status: COMPLETED
-
Study Investigating the Association of NP137 With Atezolizumab-Bevacizumab Combination in First Line in Unresectable HCC
NCT05546879 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Navigating the Clinical Trial Process for Hepatocellular Carcinoma
NCT05859945 ·Status: NOT_YET_RECRUITING
-
Expansion of Conventional Criteria for Liver Transplantation in Hepatocellular Carcinoma Through Downstaging
NCT01387503 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study to Evaluate the Safety of a 3 Weeks Sitagliptin Treatment in HCC Patients Undergoing Liver Resection
NCT02650427 ·Status: COMPLETED ·Phase: PHASE1
-
Liver Transplant Combined With Neoadjuvant Chemo-radiotherapy in the Treatment of Unresectable Hilar Cholangiocarcinoma. A Prospective Multicenter Study.
NCT04378023 ·Status: RECRUITING
-
Precision Medicine for Combined Hepatocellular-Cholangiocarcinoma
NCT06146127 ·Status: RECRUITING
-
A Study of Chromosomal Abnormalities as a Predictor of Staging and Prognosis in Patients With Liver Cancer
NCT05371873 ·Status: UNKNOWN
-
Combined Therapy Using D-TACE, Gemcitabine and Cisplatin, and PD1 Antibody in Advanced and Unresectable Intrahepatic Cholangiocarcinoma
NCT05738057 ·Status: RECRUITING ·Phase: PHASE2
-
Observational Study on Patients With Hepatocellular Carcinoma (HCC)
NCT04021056 ·Status: UNKNOWN
-
Low-Dose Radiation Therapy to the Whole Liver With Gemcitabine and Cisplatin in IHC
NCT02254681 ·Status: TERMINATED ·Phase: PHASE2
-
Gemcitabine Plus High-Dose 5-Fu/Leucovorin in the Treatment of Advanced or Metastatic Carcinoma of the Biliary Tract
NCT00201305 ·Status: COMPLETED ·Phase: PHASE2